Patel, I. et al. (2021) “Eculizumab as a Treatment for Hyper-Haemolytic and Aplastic Crisis in Sickle Cell Disease”, European Journal of Case Reports in Internal Medicine, 8(10). doi:10.12890/2021_002824.